Ermenegildo Zegna (NYSE:ZGN) reported preliminary fiscal year 2025 revenues of €1.92 billion on Monday, as the Italian luxury group successfully leveraged its direct-to-consumer (DTC) strategy to offset a challenging wholesale environment and persistent volatility in China.
Alliance Resource Partners (NASDAQ:ARLP) reported a massive surge in fourth-quarter profitability on Monday, as record oil and gas royalty volumes and improved coal operational efficiency drove a triple-digit increase in net income.
Opera (NASDAQ:OPRA) announced on Monday that its fourth-quarter and full-year 2025 performance is expected to significantly exceed its prior financial targets.
NAPCO Security Technologies (NASDAQ:NSSC) reported record fiscal second-quarter results on Monday, as the company’s high-margin recurring services business continued to reshape its profitability profile.
Tyson Foods (NYSE:TSN) reported a 5.1% increase in first-quarter revenue to $14.31 billion, surpassing Wall Street expectations as the meat giant’s diversified portfolio helped mitigate ongoing headwinds in its beef segment.
ESAB (NYSE:ESAB) announced on Monday a definitive agreement to acquire Eddyfi Technologies for $1.45 billion, marking a significant strategic pivot into the advanced non-destructive testing (NDT) and structural integrity market.
Eton Pharmaceuticals (NASDAQ:ETON) announced on Monday that it has secured U.S. marketing rights for a new ultra-rare disease product candidate, further cementing its position in the specialized orphan drug market.
Dublin-based Aptiv (NYSE:APTV), a global technology company focused on enabling a more automated, electrified, and digitalized future, today reported record financial results for the fourth quarter and full year ended December 31, 2025.
Fifth Third Bancorp (NASDAQ:FITB) finalized its merger with Comerica Incorporated on Monday, creating a regional banking powerhouse with approximately $294 billion in assets.
IDEXX Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings that surpassed analyst expectations, fueled by double-digit growth in its core companion animal business and significant margin expansion.
FEMSA (NYSE:FMX) finalized the separation of its Grupo Nós joint venture with Raízen on Monday, resulting in FEMSA assuming 100% ownership of OXXO Brazil.
Natera (NASDAQ:NTRA) submitted a formal application for U.S. regulatory approval of its Signatera molecular residual disease test as a companion diagnostic for bladder cancer, moving to solidify its lead in the burgeoning field of precision oncology.
